Lilly 4Q profit surges on diabetes drug sales

😱 76.0 😉 14.5 😠 5.2 NEW YORK (AP) - Eli Lilly and Co. on Tuesday reported a surge in fourth-quarter profit on a boost in diabetes treatment sales. The Indianapolis-based company saw profit rise 61 percent to $771.8 million, or 73 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to 95 ...